Project Details
Description
A Phase I/II Open Label Study in MPS IIIB Subjects to Investigate the Safety, Pharmacokinetics, and Pharmacodynamics/Efficacy of SBC-103 Administered Intravenously
| Status | Finished |
|---|---|
| Effective start/end date | 1/15/15 → 12/31/18 |
Funding
- SYNAGEVA BIOPHARMA CORP.
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.